34271-11-9

Upstream product

• 77833-75-1 C₆₀H₇₀N₄O₂₄ 
• 77824-09-0 Acetic acid (2R,3R,4S,5R,6R)-4,5-diacetoxy-2-[(1R,2R,3S,4R,6S)-3-((2S,3R,4R,5S,6R)-5-acetoxy-6-acetoxymethyl-4-amino-3-hydroxy-tetrahydro-pyran-2-yloxy)-4,6-diamino-2-hydroxy-cyclohexyloxy]-6-aminomethyl-tetrahydro-pyran-3-yl ester 

Downstream Products

• 70573-37-4 N-((2S,3R,4S,5S,6R)-2-{(1S,2R,3R,4S,6R)-3-[(2R,3R,4S,5S,6R)-6-(Acetylamino-methyl)-3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy]-4,6-bis-formylamino-2-hydroxy-cyclohexyloxy}-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-4-yl)-acetamide 
• 70550-97-9 3-N-formyl-3'',6'-di-N-acetylkanamycin A 

Relevant academic research and scientific papers

A HIGHLY SELECTIVE N-PROTECTION STRATEGY FOR THE PREPARATION OF 1-N-ALKYLATED KANAMYCIN ANTIBIOTICS

An O to N acyl migration technique has been used to selectively acetylate the amino groups of the aminosugar rings of kanamycins A and B, leaving the amino groups on the 2-deoxy-streptamine ring unprotected.A formylation-deformylation process then convert